Science Current Events | Science News | Brightsurf.com
 

Easy-to-use blood thinners likely to replace Coumadin

February 07, 2012
For atrial fibrillation patients at risk for stroke

MAYWOOD, Ill. -- Within a few years, a new generation of easy-to-use blood-thinning drugs will likely replace Coumadin for patients with irregular heartbeats who are at risk for stroke, according to a journal article by Loyola University Medical Center physicians.

Unlike Coumadin, the new drugs do not require patients to come in to the clinic on a regular basis to check the dose. Nor do the drugs require extensive dietary restrictions.

First author Sarkis Morales-Vidal, MD, and colleagues describe the new drugs in a review article in the February issue of the journal Expert Reviews. Co-authors are Michael J. Schneck, MD, Murray Flaster, MD, and José Biller, MD. All are in the Department of Neurology, Stroke Program, of Loyola University Chicago Stritch School of Medicine. Biller is department chair.

The new drugs include rivaroxaban (Xarelto®), dabigatran etexilate (Pradaxa®) and apixaban (Eliquis®). They do not share the disadvantages of Coumadin, and may provide equal or superior prevention against clots, Morales and colleagues write.

Atrial fibrillation is the most common form of irregular heartbeat, and a major cause of stroke in the elderly. Electrical signals, which regulate the heartbeat, become erratic. Instead of beating regularly, the upper chambers of the heart quiver. Not all the blood gets pumped out, so clots can form. The clots can migrate to the brain and cause strokes.

More than 3 million Americans have atrial fibrillation, and the number is increasing, due in part to the aging population.

Coumadin's generic name is warfarin. For more than 30 years, the drug had been the only anticoagulant for primary and secondary stroke prevention in patients with atrial fibrillation. But the Food and Drug Administration recently approved dabigatran and rivaroxaban to reduce the risk of stroke and blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. The FDA is considering an application to approve apixaban for the same use.

Coumadin must be carefully monitored. If the dose is too high, a patient could experience excessive bruising and be at higher risk for brain hemorrhages. If the dose is too low, the drug would be ineffective in preventing blood clots. Patients typically must come in at least once a month for a blood test to determine whether the dose needs to be adjusted. Some patients have to come in as often as twice a week.

Coumadin patients also must restrict their diets. For example, they should consume only small amounts of cranberry juice and alcohol and not eat large amounts of foods that are rich in vitamin K, such as spinach, brussels sprouts and green tea.

Disadvantages of the new medications include the limited clinical experience and lack of antidotes, the researchers wrote. The newer drugs are more expensive than Coumadin, but reduce the cost of patient monitoring and blood testing, Morales said.

Dabigatran is an effective alternative to Coumadin for stroke prevention in patients with non-valvular atrial fibrillation. Rivaroxaban is another promising alternative for those patients. Apixaban appears to be better than aspirin for stroke prevention in atrial fibrillation patients who are not candidates for Coumadin therapy, Morales and colleagues wrote.

The authors predict that within the next few years, the new drugs will likely replace Coumadin for long-term anticoagulation in selective patients with non-valvular atrial fibrillation.

Loyola University Health System


Related Atrial Fibrillation Current Events and Atrial Fibrillation News Articles


Digoxin associated with higher risk of death and hospitalization
Digoxin, a drug commonly used to treat heart conditions, was associated with a 71 percent higher risk of death and a 63 percent higher risk of hospitalization among adults with diagnosed atrial fibrillation and no evidence of heart failure.

Why we need to fund newer blood-thinning agents to prevent strokes
Care gaps are emerging due to disharmony between healthcare reimbursement policies and evidence-based clinical guideline recommendations, cautions a group of Canadian physicians.

Fat around the heart may cause irregular heartbeat
Obesity is a known risk factor for atrial fibrillation, the most common heart rhythm disorder.

No racial disparities in development of atrial fibrillation among heart failure patients
Black patients who have been diagnosed with heart failure are no less likely than white patients to get atrial fibrillation (an irregular heartbeat, or arrhythmia).

New study demonstrates high burden of AFib is associated with lower cognitive function
iRhythm Technologies, Inc. announced today that study results presented during the American Heart Association (AHA) Scientific Sessions showed an association between a high burden of atrial fibrillation (AFib) and lower cognitive function, specifically executive and verbal function.

Long-term overtreatment with anti-clotting/antiplatelet drug combo may raise risk of dementia
Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy with aspirin or clopidigrel to prevent stroke, may raise the risk of dementia in people with atrial fibrillation.

US emergency room visits for irregular heartbeat soar
Emergency room visits for atrial fibrillation have increased significantly in the United States -- causing a major healthcare burden, according to research presented at the American Heart Association's Scientific Sessions 2014.

Device's potential as alternative to warfarin for stroke prevention in patients with a-fib
Vivek Y. Reddy, M.D., of the Icahn School of Medicine at Mount Sinai, New York, and colleagues examined the long-term efficacy and safety, compared to warfarin, of a device to achieve left atrial appendage closure in patients with atrial fibrillation.

Higher risk of bleeding in atrial fibrillation patients taking blood thinner dabigatran
Patients with atrial fibrillation who take the blood thinner dabigatran are at greater risk for major bleeding and gastrointestinal bleeding than those who take warfarin, according to a new study by researchers at the University of Pittsburgh Graduate School of Public Health.

Dabigatran associated with higher incidence of major bleeding vs. warfarin
A study of Medicare beneficiaries suggests the anticoagulant medication dabigatran should be prescribed with caution because it appears to be associated with a higher incidence of major bleeding and a higher risk of gastrointestinal bleeding but a lower risk of intracranial hemorrhage than warfarin, according to a report published online by JAMA Internal Medicine.
More Atrial Fibrillation Current Events and Atrial Fibrillation News Articles

Beat Your A-Fib: The Essential Guide to Finding Your Cure: Written in everyday language for patients with Atrial Fibrillation

Beat Your A-Fib: The Essential Guide to Finding Your Cure: Written in everyday language for patients with Atrial Fibrillation
by Steve S Ryan PhD (Author), Patti J Ryan (Contributor)


Beat Your A-Fib: The Essential Guide to Finding Your Cure by Steve S. Ryan, PhD
Atrial Fibrillation (A-Fib) is the most common cardiac arrhythmia (abnormal heart rhythm) seen by physicians. Many patients suffering from Atrial Fibrillation have three strikes against them:
1. Their "quality of life" has deteriorated; they are scared or frightened.
2. Many experience side effects from the common drug therapies or simply do not want to live on medication; a cure for their A-Fib hasn't been discussed.
3. Patient information is often out-of-date, incomplete or biased toward a specific pharmaceutical or treatment; much information about new treatment options is written in the language of scientists and doctors.

The author, Dr. Steve Ryan, PhD, a former A-Fib patient,...

Atrial Fibrillation: What You Need to Know: A Beginner's Guide for Patients and Caregivers (Health Matters)

Atrial Fibrillation: What You Need to Know: A Beginner's Guide for Patients and Caregivers (Health Matters)
by Eternal Spiral Books, http://EternalSpiralBooks.com


++The Fifth Edition, published September 8, 2014, is now available, with updates on the latest information on atrial fibrillation, including the latest news on dabigatran, (Pradaxa), and rivaroxaban, (Xarelto), two of the blood thinning medications (anticoagulants) often prescribed for patients with atrial fibrillation, plus news on the drug digoxin, and the effectiveness of catheter ablation for AFib.

Atrial Fibrillation is a particular type of irregular heart beat which can have dangerous consequences to your health if left untreated. People with atrial fibrillation, commonly referred to as AF or AFib, are more prone to blood clots, which can lead to heart attack, stroke or even death.

Fortunately, there are a number of effective treatments available for...

The Magnesium Miracle (Revised and Updated Edition)

The Magnesium Miracle (Revised and Updated Edition)
by Carolyn Dean (Author)


REVISED AND UPDATED 2014 EDITION
 
Magnesium is an essential nutrient, indispensable to your health and well-being. By adding this mineral to your diet, you are guarding against—and helping to alleviate—such threats as heart disease, stroke, osteoporosis, diabetes, depression, arthritis, and asthma. But despite magnesium’s numerous benefits, many Americans remain dangerously deficient. Updated and revised throughout with the latest research, featuring an all-new Introduction, this amazing guide explains the vital role that magnesium plays in your body and life. Inside you will discover
 
• newly available magnesium supplements that the body absorbs more efficiently
• how calcium can increase the risk of heart disease—and how magnesium can lower it
...

A Life on Hold: Crossing Paths with Atrial Fibrillation

A Life on Hold: Crossing Paths with Atrial Fibrillation
by Kevin J Kauffman (Author)


You're going about your daily routine when you suddenly feel an odd squirming in your chest. You quickly realize that it is your heart, flopping around like a fish out of water. What do you do? You probably panic! Maybe you also experience dizziness, nausea, or shortness of breath, or maybe you have no other symptoms at all. But it's still very scary because... it's your heart! This is how chronic atrial fibrillation starts for many of us, and those who develop it often have little to no prior medical history to speak of. Once the demon a-fib has set in, though, we soon find our lives redirected down a dark uncharted path, our days consumed by vain attempts to divine the elusive origins of this mysterious malady as we desperately seek a panacea that can give us back our "normal"... or...

Medifocus Guidebook on: Atrial Fibrillation

Medifocus Guidebook on: Atrial Fibrillation
by Inc. Medifocus.com (Author)


The Medifocus Guidebook on Atrial Fibrillation is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Atrial Fibrillation, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Atrial Fibrillation, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and...

A Simple Guide to Atrial Fibrillation, Treatment and Related Conditions (A Simple Guide to Medical Conditions)

A Simple Guide to Atrial Fibrillation, Treatment and Related Conditions (A Simple Guide to Medical Conditions)


Introduction

Ode to Atrial Fibrillation

Atrial Fibrillation is an abnormal irregular heart beat
Lung diseases and hyperthyroidism contributes to it
It is caused by coronary heart disease and other heart condition
Other causes are congenital heart disease and systemic afflictions

Typically there is fast heart beats and sense of palpitations
There may chest pains and difficulty in respiration
There may congestive heart failure and ankle swelling
There are irregular heart beats and fainting

Both atrial chambers are enlarged due to irregular heart conditions
ECG will confirm the presence of atrial fibrillation
Treatment is to prevent the throwing out of blood clots
These blood clots can...

36 Ways of Stopping Palpitations. The natural way to a healthier heart and life.

36 Ways of Stopping Palpitations. The natural way to a healthier heart and life.
by Independent Publishing


This book explains the best ways of eradicating heart palpitations from your life naturally.

Palpitation sufferers should find the information within these pages of particular benefit. It encompasses all facets of research on the subject of palpitations. The final synopsis has resulted in these commonsensical ways to prevent the occurrence of palpitations. This short book integrates the research in three crucial areas: diet, supplements and lifestyle changes.

These suggestions can be incredibly beneficial to anyone suffering from heart palpitations. This includes tachycardia and even bradycardia conditions. The main benefactors of the research however, may be seen in supraventricular tachycardias, atrial flutter and atrial fibrillation conditions.

This...

How To Stop or Prevent Heart Palpitations

How To Stop or Prevent Heart Palpitations
by Stone Adams


An avid researcher and wellness enthusiast, Nick began studying heart palpitations and their risk factors back in 2002 after suffering a series of personal palpitation attacks. Determined to discover what doctors refused to disclose, Nick embarked on an enlightening journey of discovery. The results are proving to have impact not only on the issue of heart palpitations, but also on many other related health issues. "How To Stop or Prevent Heart Palpitations" looks as though it will be just the first in a series of wellness digests from Nick Walsh.

People all over the world suffer from heart palpitations that are so devastating that they lives are affected immensely. These people visit their doctors, but are told that their hearts are fine. After all of the tests are done,...

Nursing 2015 Drug Handbook, 35th Anniversary Edition (Nursing Drug Handbook)

Nursing 2015 Drug Handbook, 35th Anniversary Edition (Nursing Drug Handbook)
by Lorraine Hallowell (Editor), Karen C. Comerford (Editor)


The 35th edition of the best-selling, original drug handbook for nurses provides complete monographs for more than 900 generic and thousands of brand-name drugs. Monographs are consistently formatted for ease of use and focus on the practical information that nurses need. Each monograph consists of generic and trade names, pronunciation key, pregnancy risk category, pharmacologic class, controlled substance schedule (if applicable), available forms,  indications and dosages, administration (with drug incompatibities for I.V. drugs), action (including tables showing route, onset, peak, duration, and half-life), adverse reactions, interactions, effects on lab test results, contraindications, nursing considerations, and patient teaching.
Also includes chapters on general drug...

Atrial Fibrillation Therapy (Current Cardiovascular Therapy)

Atrial Fibrillation Therapy (Current Cardiovascular Therapy)
by Gheorghe-Andrei Dan (Editor), Antoni Bayés de Luna (Editor), John Camm (Editor)


The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.New guidelines have emerged as a result of new mechanisms for initiation and perpetuation for pharmacotherapy to cure AF and trials with new classes of antithrombotic drugs are ongoing. The treatment of AF is still in its infancy, but recent research is revealing how it can be applied with optimal efficacy. This...

© 2014 BrightSurf.com